Therefore, the present study evaluated baseline Hb as a prognostic test for the radiographic progression over time in the RA patient population enrolled in the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS) registry. The gene discussed is GSTM1; the disease is rheumatoid arthritis.